BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17016230)

  • 21. Long stemmed total knee arthroplasty with interlocking screws: a computational bone adaptation study.
    Nyman JS; Hazelwood SJ; Rodrigo JJ; Martin RB; Yeh OC
    J Orthop Res; 2004 Jan; 22(1):51-7. PubMed ID: 14656659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 23. Erectile dysfunction induced probably by celecoxib.
    Dhikav V; Gupta S; Anand KS
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):211-2. PubMed ID: 18236511
    [No Abstract]   [Full Text] [Related]  

  • 24. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-intensity pulsed ultrasound and nonsteroidal anti-inflammatory drugs have opposing effects during stress fracture repair.
    Li J; Waugh LJ; Hui SL; Burr DB; Warden SJ
    J Orthop Res; 2007 Dec; 25(12):1559-67. PubMed ID: 17593538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictions on preserving bone mass in knee arthroplasty with bisphosphonates.
    Nyman JS; Rodrigo JJ; Hazelwood SJ; Yeh OC; Martin RB
    J Arthroplasty; 2006 Jan; 21(1):106-13. PubMed ID: 16446194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT; Pucino F; Resman-Targoff BH
    J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.
    Herrera FG; Chan P; Doll C; Milosevic M; Oza A; Syed A; Pintilie M; Levin W; Manchul L; Fyles A
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):97-103. PubMed ID: 17056201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen.
    Baldassarre S; Schandene L; Choufani G; Michils A
    J Allergy Clin Immunol; 2006 Jan; 117(1):215-7. PubMed ID: 16387610
    [No Abstract]   [Full Text] [Related]  

  • 30. Celecoxib: new indication. Ankylosing spondylitis: no pain justifies the use of a cox-2 inhibitor. Patients still exposed to unjustified risks.
    Prescrire Int; 2008 Jun; 17(95):106. PubMed ID: 18627117
    [No Abstract]   [Full Text] [Related]  

  • 31. Determine whether perioperative celecoxib administration would reduce opioid consumption and provide effective pain relief in patients undergoing arthroscopic knee surgery.
    Ekman EF; Berger M; Bhadra P
    Arthroscopy; 2006 Jul; 22(7):804. PubMed ID: 16843817
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytochrome P450 2C9 genotype: impact on celecoxib safety and pharmacokinetics in a pediatric patient.
    Stempak D; Bukaveckas BL; Linder M; Koren G; Baruchel S
    Clin Pharmacol Ther; 2005 Sep; 78(3):309-10. PubMed ID: 16153401
    [No Abstract]   [Full Text] [Related]  

  • 33. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole.
    Fontaine C; Bousquet PJ; Demoly P
    J Allergy Clin Immunol; 2005 Mar; 115(3):633-4. PubMed ID: 15753917
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery.
    Holte K; Andersen J; Jakobsen DH; Kehlet H
    Br J Surg; 2009 Jun; 96(6):650-4. PubMed ID: 19434706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib-induced deep-vein thrombosis.
    Chan AL
    Ann Pharmacother; 2005 Jun; 39(6):1138. PubMed ID: 15840730
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
    Sooriakumaran P; Coley HM; Fox SB; Macanas-Pirard P; Lovell DP; Henderson A; Eden CG; Miller PD; Langley SE; Laing RW
    Anticancer Res; 2009 May; 29(5):1483-8. PubMed ID: 19443354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The addition of tramadol to morphine via patient-controlled analgesia does not lead to better post-operative pain relief after total knee arthroplasty.
    Stiller CO; Lundblad H; Weidenhielm L; Tullberg T; Grantinger B; Lafolie P; Jansson KA
    Acta Anaesthesiol Scand; 2007 Mar; 51(3):322-30. PubMed ID: 17096666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute tubulointerstitial nephritis associated with celecoxib.
    Brewster UC; Perazella MA
    Nephrol Dial Transplant; 2004 Apr; 19(4):1017-8. PubMed ID: 15031376
    [No Abstract]   [Full Text] [Related]  

  • 40. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?
    Rahme E; Barkun AN; Toubouti Y; Scalera A; Rochon S; Lelorier J
    Arthritis Rheum; 2007 Jun; 57(5):748-55. PubMed ID: 17530673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.